Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 5/2011

01.06.2011 | Original Article

Hepatic resection for liver metastases from carcinomas of the distal bile duct and of the papilla of Vater

verfasst von: Isao Kurosaki, Masahiro Minagawa, Chie Kitami, Kabuto Takano, Katsuyoshi Hatakeyama

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Hepatectomy for liver metastasis from carcinomas of the distal bile duct (BDC) and of the papilla of Vater (PVC) has not been studied in detail. The purpose of this study is to analyze risk factors of liver metastasis and to evaluate outcome of hepatectomy for liver metastasis.

Methods

Risk factors of liver metastasis were analyzed in 122 patients who underwent pancreaticoduodenectomy for BDC or PVC. In addition, 13 patients who underwent hepatectomy were reviewed.

Results

Liver metastasis after pancreaticoduodenectomy occurred in 33.8% of BDC and 26.3% of PVC patients. Multivariate analyses revealed that microvenous invasion was a significant risk factor common to BDC and PVC (p ≤ 0.05). However, 4 of the 13 resected cases survived more than 5 years (5-year survival rate, 44.9%). All four long-term survivors underwent margin-negative hepatectomy for a solitary metastasis and were given postoperative adjuvant chemotherapy. Margin-positive hepatectomy in four patients resulted in early re-recurrence of tumor. Limited hepatectomy (three cases) provided margin-positive surgery.

Conclusions

Hepatectomy for a solitary metastasis is the treatment of choice even after pancreaticoduodenectomy, but indication of hepatectomy for multiple metastases is still limited. The combination of surgery and adjuvant chemotherapy should be studied further to improve survival rates.
Literatur
1.
Zurück zum Zitat Adam R, Chiche L, Aloia T et al (2006) Association Française de Chirurgie. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1, 452 patients and development of a prognostic model. Ann Surg 244:524–535PubMedCrossRef Adam R, Chiche L, Aloia T et al (2006) Association Française de Chirurgie. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1, 452 patients and development of a prognostic model. Ann Surg 244:524–535PubMedCrossRef
2.
Zurück zum Zitat Yamamoto J, Sugihara K, Kosuge T et al (1995) Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg 221:74–78PubMedCrossRef Yamamoto J, Sugihara K, Kosuge T et al (1995) Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg 221:74–78PubMedCrossRef
3.
Zurück zum Zitat Riopel MA, Klimstra DS, Godellas CV, Blumgart LH, Westra WH (1997) Intrabiliary growth of metastatic colonic adenocarcinoma: a pattern of intrahepatic spread easily confused with primary neoplasia of the biliary tract. Am J Surg Pathol 21:1030–1036PubMedCrossRef Riopel MA, Klimstra DS, Godellas CV, Blumgart LH, Westra WH (1997) Intrabiliary growth of metastatic colonic adenocarcinoma: a pattern of intrahepatic spread easily confused with primary neoplasia of the biliary tract. Am J Surg Pathol 21:1030–1036PubMedCrossRef
4.
Zurück zum Zitat Todoroki T, Kawamoto T, Koike N et al (2001) Treatment strategy for patients with middle and lower third bile duct cancer. Br J Surg 88:364–370PubMedCrossRef Todoroki T, Kawamoto T, Koike N et al (2001) Treatment strategy for patients with middle and lower third bile duct cancer. Br J Surg 88:364–370PubMedCrossRef
5.
Zurück zum Zitat Cheng Q, Luo X, Zhang B, Jiang X, Yi B, Wu M (2007) Distal bile duct carcinoma: prognostic factors after curative surgery. A series of 112 cases. Ann Surg Oncol 14:1212–1219PubMedCrossRef Cheng Q, Luo X, Zhang B, Jiang X, Yi B, Wu M (2007) Distal bile duct carcinoma: prognostic factors after curative surgery. A series of 112 cases. Ann Surg Oncol 14:1212–1219PubMedCrossRef
6.
Zurück zum Zitat Sasaki R, Takahashi M, Funato O et al (2001) Prognostic significance of lymph node involvement in middle and distal bile duct cancer. Surgery 129:677–683PubMedCrossRef Sasaki R, Takahashi M, Funato O et al (2001) Prognostic significance of lymph node involvement in middle and distal bile duct cancer. Surgery 129:677–683PubMedCrossRef
7.
Zurück zum Zitat Takao S, Shinchi H, Uchikura K, Kubo M, Aikou T (1999) Liver metastases after curative resection in patients with distal bile duct cancer. Br J Surg 86:327–331PubMedCrossRef Takao S, Shinchi H, Uchikura K, Kubo M, Aikou T (1999) Liver metastases after curative resection in patients with distal bile duct cancer. Br J Surg 86:327–331PubMedCrossRef
8.
Zurück zum Zitat Woo SM, Ryu JK, Lee SH et al (2007) Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma. Ann Surg Oncol 14:3195–3201PubMedCrossRef Woo SM, Ryu JK, Lee SH et al (2007) Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma. Ann Surg Oncol 14:3195–3201PubMedCrossRef
9.
Zurück zum Zitat de Castro SM, Kuhlmann KF, van Heek NT et al (2004) Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy. J Gastrointest Surg 8:775–784PubMedCrossRef de Castro SM, Kuhlmann KF, van Heek NT et al (2004) Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy. J Gastrointest Surg 8:775–784PubMedCrossRef
10.
Zurück zum Zitat Hsu HP, Yang TM, Hsieh YH, Shan YS, Lin PW (2007) Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer. Ann Surg Oncol 14:50–60PubMedCrossRef Hsu HP, Yang TM, Hsieh YH, Shan YS, Lin PW (2007) Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer. Ann Surg Oncol 14:50–60PubMedCrossRef
11.
Zurück zum Zitat Kim RD, Kundhal PS, McGilvray ID et al (2006) Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. J Am Coll Surg 202:112–119PubMedCrossRef Kim RD, Kundhal PS, McGilvray ID et al (2006) Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. J Am Coll Surg 202:112–119PubMedCrossRef
12.
Zurück zum Zitat Todoroki T, Koike N, Morishita Y et al (2003) Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann Surg Oncol 10:1176–1183PubMedCrossRef Todoroki T, Koike N, Morishita Y et al (2003) Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann Surg Oncol 10:1176–1183PubMedCrossRef
13.
Zurück zum Zitat Jang JY, Kim SW, Park DJ et al (2005) Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg 241:77–84PubMed Jang JY, Kim SW, Park DJ et al (2005) Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg 241:77–84PubMed
14.
Zurück zum Zitat Takada Y, Otsuka M, Seino K et al (2001) Hepatic resection for metastatic tumors from noncolorectal carcinoma. Hepatogastroenterology 48:83–86PubMed Takada Y, Otsuka M, Seino K et al (2001) Hepatic resection for metastatic tumors from noncolorectal carcinoma. Hepatogastroenterology 48:83–86PubMed
15.
Zurück zum Zitat Sugimoto M, Takada T, Yasuda H et al (2005) Exceptional ultra-late recurrence of papilla Vater carcinoma after pancreaticoduodenectomy: two cases at 17 and 25 years. Hepatogastroenterology 52:940–943PubMed Sugimoto M, Takada T, Yasuda H et al (2005) Exceptional ultra-late recurrence of papilla Vater carcinoma after pancreaticoduodenectomy: two cases at 17 and 25 years. Hepatogastroenterology 52:940–943PubMed
16.
Zurück zum Zitat Okusaka T, Nakachi K, Fukutomi A et al (2010) Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer 103:469–474PubMedCrossRef Okusaka T, Nakachi K, Fukutomi A et al (2010) Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer 103:469–474PubMedCrossRef
17.
Zurück zum Zitat Sano T, Nimura Y, Hayakawa N et al (1997) Partial hepatectomy for metastatic seeding complicating pancreatoduodenectomy. Hepatogastroenterology 44:263–267PubMed Sano T, Nimura Y, Hayakawa N et al (1997) Partial hepatectomy for metastatic seeding complicating pancreatoduodenectomy. Hepatogastroenterology 44:263–267PubMed
18.
Zurück zum Zitat Kitami CE, Kurosaki I, Koyama Y et al (2005) Long-term survival after hepatectomy for hepatic recurrence of carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg 12:321–323PubMedCrossRef Kitami CE, Kurosaki I, Koyama Y et al (2005) Long-term survival after hepatectomy for hepatic recurrence of carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg 12:321–323PubMedCrossRef
19.
Zurück zum Zitat Sasaki R, Takeda Y, Hoshikawa K et al (2004) Resection of liver metastasis from extrahepatic bile duct carcinoma previously treated by pancreatoduodenectomy. Hepatogastroenterology 51:245–246PubMed Sasaki R, Takeda Y, Hoshikawa K et al (2004) Resection of liver metastasis from extrahepatic bile duct carcinoma previously treated by pancreatoduodenectomy. Hepatogastroenterology 51:245–246PubMed
20.
Zurück zum Zitat Fujii K, Yamamoto J, Shimada K, Kosuge T et al (1999) Resection of liver metastases after pancreatoduodenectomy: report of seven cases. Hepatogastroenterology 4628:2429–2433 Fujii K, Yamamoto J, Shimada K, Kosuge T et al (1999) Resection of liver metastases after pancreatoduodenectomy: report of seven cases. Hepatogastroenterology 4628:2429–2433
21.
Zurück zum Zitat de Jong MC, Tsai S, Cameron JL et al (2010) Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis. J Surg Oncol 102:256–263PubMedCrossRef de Jong MC, Tsai S, Cameron JL et al (2010) Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis. J Surg Oncol 102:256–263PubMedCrossRef
22.
Zurück zum Zitat Valle J, Wasan H, Palmer DH et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273–1281PubMedCrossRef Valle J, Wasan H, Palmer DH et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273–1281PubMedCrossRef
23.
Zurück zum Zitat Kurosaki I, Hatakeyama K (2005) Repeated hepatectomy for recurrent intrahepatic cholangiocarcinoma: report of two cases. Eur J Gastroenterol Hepatol 17:125–130PubMedCrossRef Kurosaki I, Hatakeyama K (2005) Repeated hepatectomy for recurrent intrahepatic cholangiocarcinoma: report of two cases. Eur J Gastroenterol Hepatol 17:125–130PubMedCrossRef
Metadaten
Titel
Hepatic resection for liver metastases from carcinomas of the distal bile duct and of the papilla of Vater
verfasst von
Isao Kurosaki
Masahiro Minagawa
Chie Kitami
Kabuto Takano
Katsuyoshi Hatakeyama
Publikationsdatum
01.06.2011
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 5/2011
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-011-0752-4

Weitere Artikel der Ausgabe 5/2011

Langenbeck's Archives of Surgery 5/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.